Establishing Diagnostic Reference Levels for Single-Photon Emission Computed Tomography (SPECT) Imaging: A Preliminary Study in Indian Healthcare Settings
Abstract
Introduction In nuclear medicine, there is a critical need to balance the control and optimization of radiation doses to ensure patient safety while achieving high-quality diagnostic outcomes. However, diagnostic reference levels (DRLs) for nuclear medicine imaging studies have not been established in India. This study aims to fill this gap by establishing institutional DRLs and assessing radiation dose data specifically for Nuclear Medicine SPECT examinations. Methods This research was a cross-sectional observational study conducted in a single tertiary care setting, involving 1,250 patients. Data on the administered activity for 18 common single photon emission computed tomography (SPECT) procedures were gathered from 2019 to 2021. The 75th percentile (Q3) was established as the baseline for the institutional DRLs. Furthermore, the study conducted comparative analyses with established international DRLs. Results The study proposed institutional DRLs based on 18 SPECT nuclear medicine imaging examinations. The highest Q3 DRLs were identified for 99mTc-sestamibi (1193 MBq), followed by 99mTc-methylene diphosphonate (747 MBq) and 99mTc-ethyl cysteinate dimer (608 MBq). The lowest DRL was recorded for 99mTc gastric emptying imaging (37 MBq). Comparisons with international DRLs indicated close alignment with European Association of Nuclear Medicine Medical Internal Radiation Dose guidelines, while DRLs set by the National Council on Radiation Protection and Measurements (NCRP)…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 1,250 participants or records.
Read the paper
Related studies
- Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
- A meta‐analysis of anal cancer incidence by risk group: Toward a unified anal cancer risk scale
- Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
- Exercise interventions in Alzheimer's disease: A systematic review and meta-analysis of randomized controlled trials
- Prognostic Significance of Carbonic Anhydrase IX Expression in Cancer Patients: A Meta-Analysis
- Glucocorticoid Resistance: Is It a Requisite for Increased Cytokine Production in Depression? A Systematic Review and Meta-Analysis
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.